Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADVICE: Ciclesonide/Formoterol Dose Finding in Asthma
NCT00314509Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Jul 2005
- Primary completion
- Jan 2006
- Modality
- Orthosteric Ligands
- Countries
- 4
01
Overview
A Phase 2 trial of ciclesonide, formoterol in asthma, sponsored by AstraZeneca. Started Jul 2005; status: completed.
02
Drugs
ciclesonideformoterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00314509.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00314509.